|
positive regulation of cardiac muscle cell apoptotic process
|
GO_0010666 |
[Any process that increases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.] |
|
negative regulation of cardiac muscle cell apoptotic process
|
GO_0010667 |
[Any process that decreases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.] |
|
ectodermal cell differentiation
|
GO_0010668 |
[The process in which relatively unspecialized cells acquire specialized structural and/or functional features of an ectodermal cell. Differentiation includes the processes involved in commitment of a cell to a specific fate.] |
|
sinoatrial node cell development
|
GO_0060931 |
[The process whose specific outcome is the progression of a sinoatrial (SA) node cell over time, from its formation to the mature state. SA node cells are pacemaker cells that are found in the sinoatrial node.] |
|
His-Purkinje system cell differentiation
|
GO_0060932 |
[The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of a cell of the His-Purkinje system. These cells form the fibers regulate cardiac muscle contraction in the ventricles.] |
|
His-Purkinje system cell
|
CL_0010007 |
|
|
His-Purkinje system development
|
GO_0003164 |
[The process whose specific outcome is the progression of the His-Purkinje system over time, from its formation to the mature structure. The His-Purkinje system receives signals from the AV node and is composed of the fibers that regulate cardiac muscle contraction in the ventricles.] |
|
negative regulation of axonemal microtubule depolymerization
|
GO_0007027 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the depolymerization of the specialized microtubules of the axoneme.] |
|
negative regulation of microtubule depolymerization
|
GO_0007026 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol.] |
|
axonemal microtubule depolymerization
|
GO_0060404 |
[The removal of tubulin heterodimers from one or both ends of an axonemal microtubule. An axonemal microtubule is a microtubule in the axoneme of a cilium or flagellum; an axoneme contains nine modified doublet microtubules surrounding a pair of single microtubules.] |
|
negative regulation of protein depolymerization
|
GO_1901880 |
[Any process that stops, prevents or reduces the frequency, rate or extent of protein depolymerization.] |
|
cardiac fibroblast cell differentiation
|
GO_0060935 |
[The process in which a relatively unspecialized cell acquires the specialized structural and/or functional features of a cardiac fibroblast. A cardiac fibroblast is a connective tissue cell in the heart which secretes an extracellular matrix rich in collagen and other macromolecules.] |
|
fibroblast of cardiac tissue
|
CL_0002548 |
[A fibroblast that is part of the heart.] |
|
cardiac fibroblast cell development
|
GO_0060936 |
[The process whose specific outcome is the progression of a cardiac fibroblast over time, from its formation to the mature state. A cardiac fibroblast is a connective tissue cell of the heart which secretes an extracellular matrix rich in collagen and other macromolecules.] |
|
cytoplasm organization
|
GO_0007028 |
[A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the cytoplasm. The cytoplasm is all of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.] |
|
His-Purkinje system cell development
|
GO_0060933 |
[The process whose specific outcome is the progression of a His-Purkinje cell over time, from its formation to the mature state. These cells form the fibers that regulate cardiac muscle contraction in the ventricles.] |
|
carcinoembryonic antigen-related cell adhesion molecule 8 proteolytic cleavage product
|
PR_000018406 |
[A carcinoembryonic antigen-related cell adhesion molecule 8 that has been processed by proteolytic cleavage.] |
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
PR_000001332 |
[A protein that is a translation product of the human CEACAM8 gene or a 1:1 ortholog thereof.] |
|
General Qualifier
|
NCIT_C27993 |
[A term that helps define and render another concept unique.] |
|
Qualifier
|
NCIT_C41009 |
[A term that helps define and render a concept unique.] |